Monopar Therapeutics
MNPR
#7604
Rank
S$0.42 B
Marketcap
$70.31
Share price
7.08%
Change (1 day)
3,046.48%
Change (1 year)

Monopar Therapeutics (MNPR) - Total debt

Total debt on the balance sheet as of December 2023 : N/A

According to Monopar Therapeutics's latest financial reports the company's total debt is N/A. A companyโ€™s total debt is the sum of all current and non-current debts.

Monopar Therapeutics - Total debt on balance sheet (from 2020 to 2023)

Total debt by year

Year Total debt Change
2022-12-31S$0.01 M
2021-12-31N/A

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
S$4.22 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA